BMS986278
oral LPA1 GPCR receptor antagonist Ph. II candidate for IPF (60 mg BID) from addressing tox. of prior candidate Journal of Medicinal Chemistry Bristol Myers Squibb, Princeton, NJ
Molecules of the Month - October 2021
Molecules of the Month
- BMS986278
- compound 4c
- AS-0141
- aficamten
- CP-628006
- reldesemtiv
- JNJ-A07
- eliapixant
- repotrectinib
- compound 10
- venglustat
- maralixibat
- compound 44
- compound 1